Biotech nicely has outperformed the overall market so far in 2020. With scores of concerns working on Covid-19 treatments, tests and vaccines supported by the government and drug manufacturers deemed as essential businesses, that should be not be surprisingThe SPDR S&P Biotech ETF (XBI) has rallied hard over the month and is near 52-week highsSo, ...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.